Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
19.59
+0.02 (0.10%)
May 13, 2025, 3:04 PM CST
SHE:300122 Revenue
Chongqing Zhifei Biological Products had revenue of 2.37B CNY in the quarter ending March 31, 2025, a decrease of -79.16%. This brings the company's revenue in the last twelve months to 17.05B, down -67.92% year-over-year. In the year 2024, Chongqing Zhifei Biological Products had annual revenue of 26.07B, down -50.74%.
Revenue (ttm)
17.05B
Revenue Growth
-67.92%
P/S Ratio
2.75
Revenue / Employee
2.36M
Employees
7,220
Market Cap
46.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 26.07B | -26.85B | -50.74% |
Dec 31, 2023 | 52.92B | 14.65B | 38.30% |
Jan 1, 2023 | 38.26B | 7.61B | 24.83% |
Dec 31, 2021 | 30.65B | 15.46B | 101.79% |
Dec 31, 2020 | 15.19B | 4.60B | 43.48% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Sichuan Biokin Pharmaceutical | 5.82B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |